Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis

Status:
Completed

Trial end date:
2018-02-14

Target enrollment:

Participant gender:

The purpose of this study is to determine whether etrasimod is a safe and effective treatment for ulcerative colitis.

Phase 2

Arena Pharmaceuticals